Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplan (Q46836508)
Jump to navigation
Jump to search
scientific article published in January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplan |
scientific article published in January 2006 |
Statements
1 reference
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplan (English)
1 reference
John Kuruvilla
1 reference
Tracy Nagy
1 reference
Melania Pintilie
1 reference
Richard Tsang
1 reference
Armand Keating
1 reference
Michael Crump
1 reference
1 January 2006
1 reference
1 reference
106
1 reference
2
1 reference
353-360
1 reference
Identifiers
1 reference